Tevogen Bio

Developer of T-cell therapies for viral diseases and cancers

placeNew Jersey, United States calendar_todayFounded 2020 groups26 employees language tevogen.com

Innovation

4 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 87 times.

YearFilings
20211
20222
20232
20242
20251

Investor mix

2 investors on record; lead investors include HMP Global.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon